Thrombin alfa
Key facts
| Active substance |
thrombin alfa
|
| Therapeutic area |
Haematology-Hemostaseology
|
| Decision number |
P/62/2008
|
| PIP number |
Thrombin alfa
|
| Pharmaceutical form(s) |
Powder and solvent for reconstitution
|
| Condition(s) / indication(s) |
Haemorrhage complicating a surgical procedure
|
| Route(s) of administration |
Epilesional use
|
| Contact for public enquiries |
Bayer HealthCare AG
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|